NCT07182526View on ClinicalTrials.gov

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

PHASE2RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Interventions

DRUG

Quercetin

Quercetin 500 mg capsule daily after meal for three months

DRUG

Alpha Lipoic Acid 600 MG Oral Tablet

Alpha lipoic acid 600mg SR capsule daily after meal for three months period.

DRUG

MetFORMIN 500 Mg Oral Tablet

metformin 500 mg daily for three months

Trial Locations (1)

00964

RECRUITING

Mustansiriyah University/ College of Pharmacy, Baghdad

All Listed Sponsors

lead

Al-Mustansiriyah University

OTHER

NCT07182526 - Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter